Changing pattern in the clinical presentation of pediatric celiac disease: a 30-year study

Eleftheria Roma1, Joanna Panayiotou, Helen Karantana

  • 1First Department of Pediatrics of Athens University, Aghia Sophia Children's Hospital, Athens, Greece. roma2el@otenet.gr

Digestion
|September 25, 2009
PubMed

Insights

Pediatric celiac disease (CD) presentation is changing in Greece, with more diagnoses in older children and atypical symptoms. Increased serological screening detects silent cases, highlighting the need for broader diagnostic consideration.

Area of Science:

  • Pediatrics
  • Gastroenterology
  • Epidemiology

Background:

  • Celiac disease (CD) incidence has risen due to better recognition of atypical and silent forms.
  • Serological screening aids in identifying previously undiagnosed cases of CD.
  • Understanding temporal trends in pediatric CD presentation is crucial for public health.

Purpose of the Study:

  • To analyze temporal trends in the clinical presentation of pediatric celiac disease in Greece.
  • To investigate changes in diagnostic patterns and patient demographics over time.
  • To identify shifts in symptomology and detection methods for pediatric CD.

Main Methods:

  • Retrospective review of medical records for children diagnosed with CD between 1978 and 2007.
  • Classification of cases by year of diagnosis to assess temporal changes.
  • Analysis of demographic data, presenting symptoms, diagnostic delay, and associated conditions.

Main Results:

  • A significant increase in pediatric CD incidence was observed in recent years.
  • Trends indicated older age at diagnosis, longer diagnostic delays, and a decrease in classical gastrointestinal symptoms.
  • CD diagnosis increasingly resulted from screening asymptomatic children with family or associated condition history.

Conclusions:

  • The presentation of pediatric celiac disease in Greece is evolving.
  • CD is now more frequently diagnosed in older children, often with atypical symptoms.
  • Increased serological screening contributes to earlier detection, emphasizing consideration of CD in diverse clinical scenarios.
Abstract

Related Concept Videos

Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...